FI20002612A0 - Yhdistelmäterapia serotoniinivälityksen häiriöiden hoitamiseksi - Google Patents

Yhdistelmäterapia serotoniinivälityksen häiriöiden hoitamiseksi

Info

Publication number
FI20002612A0
FI20002612A0 FI20002612A FI20002612A FI20002612A0 FI 20002612 A0 FI20002612 A0 FI 20002612A0 FI 20002612 A FI20002612 A FI 20002612A FI 20002612 A FI20002612 A FI 20002612A FI 20002612 A0 FI20002612 A0 FI 20002612A0
Authority
FI
Finland
Prior art keywords
disorders
treatment
combination therapy
serotonin turnover
serotonin
Prior art date
Application number
FI20002612A
Other languages
English (en)
Swedish (sv)
Inventor
Outi Maeki-Ikola
Original Assignee
Orion Yhtymae Oyj
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtymae Oyj filed Critical Orion Yhtymae Oyj
Priority to FI20002612A priority Critical patent/FI20002612A0/fi
Publication of FI20002612A0 publication Critical patent/FI20002612A0/fi
Priority to AU2002218335A priority patent/AU2002218335A1/en
Priority to PCT/FI2001/001029 priority patent/WO2002043724A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI20002612A 2000-11-28 2000-11-28 Yhdistelmäterapia serotoniinivälityksen häiriöiden hoitamiseksi FI20002612A0 (fi)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FI20002612A FI20002612A0 (fi) 2000-11-28 2000-11-28 Yhdistelmäterapia serotoniinivälityksen häiriöiden hoitamiseksi
AU2002218335A AU2002218335A1 (en) 2000-11-28 2001-11-27 Combination therapy for treatment of serotonergic disorders
PCT/FI2001/001029 WO2002043724A1 (en) 2000-11-28 2001-11-27 Combination therapy for treatment of serotonergic disorders

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20002612A FI20002612A0 (fi) 2000-11-28 2000-11-28 Yhdistelmäterapia serotoniinivälityksen häiriöiden hoitamiseksi

Publications (1)

Publication Number Publication Date
FI20002612A0 true FI20002612A0 (fi) 2000-11-28

Family

ID=8559601

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20002612A FI20002612A0 (fi) 2000-11-28 2000-11-28 Yhdistelmäterapia serotoniinivälityksen häiriöiden hoitamiseksi

Country Status (3)

Country Link
AU (1) AU2002218335A1 (fi)
FI (1) FI20002612A0 (fi)
WO (1) WO2002043724A1 (fi)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004037238A1 (en) * 2002-10-23 2004-05-06 Orion Corporation New uses of deramciclane

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU179164B (en) * 1979-12-14 1982-08-28 Egyt Gyogyszervegyeszeti Gyar Process for producing cycloalkyl-ethers of alkanolamines
HU226061B1 (en) * 1996-10-17 2008-04-28 Egis Gyogyszergyar Nyilvanosan 1,7,7-trimethyl-bicyclo[2.2.1]heptane derivative, pharmaceutical compositions containing the same and process for their preparation
UA77650C2 (en) * 1999-12-06 2007-01-15 Lundbeck & Co As H Use of serotonin reuptake inhibitor in combination with deramcyclane
EP1133986A1 (en) * 2000-03-17 2001-09-19 Orion Corporation Use of deramciclane for the treatment of anxiety and depression

Also Published As

Publication number Publication date
WO2002043724A1 (en) 2002-06-06
AU2002218335A1 (en) 2002-06-11

Similar Documents

Publication Publication Date Title
NO20005884D0 (no) Kombinasjonsterapi for behandling av bipolare forstyrrelser
HK1152243A1 (en) Vegf for use in the treatment of central nervous system disorders vegf
PT1147114E (pt) Novos aralquilaminas de espirofuropiridinas uteis em terapia.
IS6560A (is) Lyfjasamsetning fyrir meðhöndlun á bráðum, þrálátum sársauka og/eða taugakerfissársauka og mígreni
NO20044054L (no) Administrering av midler for behandling av betennelse
CY2014005I1 (el) Τοπικα συστηματα παροχης γελης για την θεραπευτικη αντιμετωπιση των διαταραχων δερματος
ATE472325T1 (de) Intrakorporale medikamente zur photodynamischen behandlung von erkrankungen
HK1092367A1 (en) Combination therapy for the treatment of ocular neovascular disorders
ATE320257T1 (de) (s,s)-reboxetine zur behandlung chronischer schmerzen
NO20021845L (no) Behandling av sovnforstyrrelser under anvendelse av desloratadin
NO20031903L (no) Nye amidoalkylpiperidin- og amidoalkylpiperazinderivater for anvendelse vedbehandling av nervesystemlidelser
DK1702618T3 (da) Brug af ET743 i kombinationsterapi med dexamethason til behandling af cancer
EP1631297A4 (en) TREATMENT OF IMMUNOSTIC DISEASES WITH ACTIVE VITAMIN D COMPOUNDS ALONE OR IN COMBINATION WITH OTHER THERAPEUTICS
IS6137A (is) Meðhöndlun á hugsýkistruflunum
ZA200003236B (en) Combination therapy for the treatment of migraine.
EE9900118A (et) H+,K+-ATPaasi inhibiitorite kasutamine ninapolüüpide ravimisel
NO20023448L (no) Medikamentkombinasjon for behandling av depresjon og beslektede forstyrrelser omfattende mirtazapin
ZA200110436B (en) Therapeutic use of melatonin.
AU2003259246A8 (en) Methods for the use of neurotoxin in the treatment of urologic disorders
NO20023803L (no) Anvendelse av mirtazapin for behandling av sövnforstyrrelser
NO20020784D0 (no) Medikament for behandling av brudd
NO20043445L (no) Kombinasjonsterapi for behandling av bakterielle infeksjoner
PT1305307E (pt) Derivados de indole eficazes no tratamento de doencas do sistema nervoso central
EE200100527A (et) Osanetandi kasutamine meeleoluhäirete raviks kasulike ravimite valmistamiseks
NO20012612D0 (no) Isonipecotamider for behandling av integren-formidlede lidelser